Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
ASX:IMR
Want to see AU:IMR full AI Analyst Report?
IMR Stock Chart & Stats
AU$1.64
--
Market closed
AU$1.64
--
Day’s Range― - ―
52-Week RangeAU$1.15 - AU$2.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)287.54K
Market Cap
AU$558.45M
Enterprise ValueAU$321.78M
Total Cash (Recent Filing)AU$40.81M
Total Debt (Recent Filing)AU$26.62M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Sep 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding320,947,020
10 Day Avg. Volume240,875
30 Day Avg. Volume287,535
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)27.34
Price to Sales (P/S)1042.05
P/FCF Ratio-15.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.78Price Target Upside69.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.07
Revenue Forecast (FY)AU$3.42M
Bulls Say, Bears Say
Bulls Say
MRI-compatible EP Product NicheImricor’s core focus on MRI-compatible electrophysiology systems is a durable strategic niche. MRI-guided ablation requires specialized hardware, software and regulatory work—creating technical and regulatory barriers to entry that support sustained competitive advantage if clinical adoption rises.
Equity Turned Positive In 2025The swing to positive equity provides a meaningful balance-sheet buffer against insolvency risk. That improvement enhances financial flexibility and credibility with lenders and partners, reducing immediate default risk and helping fund near-term development and regulatory milestones without urgent recapitalization.
Improving Free Cash Flow TrendA smaller free cash flow deficit indicates early operational progress in lowering cash burn. While still negative, the improving trend suggests management is finding efficiencies or phasing investments, which can extend runway and increase the chance of reaching commercialization inflection points without immediate large financings.
Bears Say
Collapsing Revenue & Negative Gross ProfitRevenue is extremely small and fell sharply in 2025, undermining unit economics and the firm's ability to absorb fixed costs. Persistently negative gross margins indicate structural cost or pricing issues, making it difficult to scale to profitability without material changes to product costs, pricing or adoption.
Consistent Heavy Cash BurnSustained, large operating cash outflows deplete resources and force reliance on external funding. With negative operating cash flow each year and sizable annual deficits, the company faces persistent dilution or refinancing risk that constrains long-term investment in commercialization and product development.
Elevated Debt And LeverageHigh leverage relative to equity limits financial flexibility and raises refinancing and interest burden risk. Combined with ongoing losses, elevated debt increases the chance management must pursue dilutive capital raises or restructurings, constraining the firm's ability to fund growth initiatives sustainably.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh News
IMR FAQ
What was Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price range in the past 12 months?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh lowest share price was AU$1.15 and its highest was AU$2.25 in the past 12 months.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap is AU$558.45M.
When is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date is Sep 01, 2026 which is in 85 days.
How were Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s earnings last quarter?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, beating the consensus estimate of -AU$0.032 by AU$0.032.
Is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh overvalued?
According to Wall Street analysts Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price is currently Undervalued.
Does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh pay dividends?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh does not currently pay dividends.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate is 0.
How many shares outstanding does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh have?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 320,947,020 shares outstanding.
What happened to Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price movement after its last earnings report?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh reported an EPS of AU$0 in its last earnings report, beating expectations of -AU$0.032. Following the earnings report the stock price went up 1.508%.
Which hedge fund is a major shareholder of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh?
Currently, no hedge funds are holding shares in AU:IMR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$2.78 (69.51% Upside)
AU$2.78 (69.51% Upside)
Blogger Sentiment
Bullish
AU:IMR Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
102.70%
12-Months-Change
Fundamentals
Return on Equity
-109.63%
Trailing 12-Months
Asset Growth
96.47%
Trailing 12-Months
Company Description
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR) Earnings & Revenues
IMR Stock 12 Month Forecast
Average Price Target
AU$2.78
▲(69.51% Upside)
Technical Analysis
Impedimed Limited
―
HeraMED Ltd.
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Options Prices
Currently, No data available
---